Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects

Recruiting now

Conditions studied: Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis

In brief

This study evaluates hematopoiesis to determine how MBL/CLL affected bone marrow responds to fight off infections in the body.

Key facts

Study ID

NCT06536452

Run by

Mayo Clinic

People needed

50

Starts

2016-11-18

Expected to finish

2028-11-18

Last updated by the study team

2026-03-31

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects in the CLL cohort who are eligible for these studies will have a clinically established diagnosis of CLL as assessed by flow cytometry and will include subjects who
• Remain untreated
• Are currently being treated
• Who have already been treated
• Subjects in the MBL cohort will have a clinically established diagnosis of MBL
• Healthy age-matched control subjects
• Healthy younger control subjects aged > 40 years

You may not qualify if…

• Anyone under 40
• Healthy control subjects must not have a diagnosis of CLL or MBL

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.